Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis

Rationale. Rheumatoid arthritis (RA) and systemic juvenile arthritis (sJA) are the most frequent rheumatic diseases in adults and adolescents, consequently. Biologics disease modifying antirheumatic drugs (bDMARDs) are eff ective in treatment of RA and s JA. Aim. To perform health-economic analysis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: A. S. Kolbin, A. A. Kurylev, S. A. Mishinova, Yu. E. Balykina, M. A. Proskurin
Formato: Artigo
Idioma:Russo
Publicado em: Izdatelstvo OKI 2020-05-01
Colecção:Качественная клиническая практика
Assuntos:
rheumatoid arthritis
tnf-α inhibitors
healtheconomics
Acesso em linha:https://www.clinvest.ru/jour/article/view/486
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados